If you or someone you care about is taking Invokana (canagliflozin) for type 2 diabetes, you need to know how to recognize the signs of kidney failure. Kidney failure is fatal if left untreated. Those who are treated early enough may avoid permanent injury. Invokana was linked to at least 54 cases of renal impairment and kidney failure in its first … [Read more...]

Invokana (canagliflozin) was the first in a new class of drugs used to treat type 2 diabetes, called sodium-glucose cotransporter-2 (SGLT2) inhibitors, to receive approval by the U.S. Food and Drug Administration. (FDA). It was approved in March, 2013, and within a year of hitting the market the drug had been linked to at least 457 serious adverse … [Read more...]

Invokana (canagliflozin) is in a new class of drugs used to treat type 2 diabetes, called sodium-glucose cotransporter-2 (SGLT2) inhibitors. Invokana’s use has been linked to a dangerous medical condition called ketoacidosis. Diabetic ketoacidosis often requires hospitalization and can be fatal. If you or someone you love has suffered ketoacidosis … [Read more...]